Noun
vedolizumab (uncountable)
(pharmacology) A monoclonal antibody under investigation for the treatment of ulcerative colitis and Crohn's disease.
There have been reports of increased post-operative complications with vedolizumab, but in this study there did not appear to be an increase with the drug." Source: Internet
The mean vedolizumab exposure/follow-up period was 27.3 weeks in 15 studies. Source: Internet
Eventually, Haupert found two therapies that helped improve her health: the anti-inflammatory drug Entyvio (vedolizumab), which she receives every eight weeks by infusion at the hospital, and regular physical activity. Source: Internet